Company Overview - Suzhou Pusi Medical recently completed nearly 100 million yuan in Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Technology [1] - The funding will accelerate the industrialization of the low helium siphon cooling technology PhaseXCool® in superconducting magnet devices, including MRI equipment, industrial magnetic single crystal systems, and precision scientific instruments [1] Technology and Innovation - The core breakthrough of Pusi Medical's new generation low helium magnet is the reduced reliance on liquid helium, utilizing a GM cooler secondary cold head (3-4K) as a cooling source [3] - The PhaseXCool® technology achieves effective heat exchange for key components of the magnet, allowing stable operation below 4.2K with significantly lower helium consumption [2][3] - The new technology features a closed-loop self-circulation system that eliminates helium leakage and quenching risks, reducing downtime recovery to one-third of traditional equipment [4] Market Potential - The global MRI equipment market is projected to grow from approximately $7.1 billion in 2024 to $10.3 billion by 2030, indicating a strong growth trajectory [6] - The low helium MRI market is expected to expand from $2.8 billion in 2024 to $5.9 billion by 2033, highlighting the demand for this innovative technology [6] - Pusi Medical plans to deliver the first batch of 3.0T low helium superconducting magnets for system testing to domestic clients by June next year, with industrial magnetic single crystal magnets expected by the end of the year [5]